AliveCor has been granted FDA clearance for KardiaMobile 6L, the world’s first publicly available six-lead personal electrocardiogram device.

Omron Healthcare launched its latest innovation, Complete, May 1, marking the first time a blood pressure (BP) monitor with electrocardiogram (ECG) capabilities has hit the commercial market.

Cardio-oncology has emerged as an area of rapid growth in the medical community in recent years, owing in large part to an increasing population of cancer survivors.

Catheter-directed therapy (CDT) is being used to treat pulmonary embolism (PE) more and more by healthcare providers, according to new research published in the Journal of Vascular and Interventional Radiology.

The same genetic variants that have been uncovered in patients with two other types of cardiomyopathy are also present in an uncommonly high proportion of people with cancer therapy-induced cardiomyopathy (CCM), researchers reported in Circulation.

A deep learning model trained on more than 1.5 million electrocardiograms can reliably detect hyperkalemia—or abnormally high potassium levels in the blood—among patients with chronic kidney disease (CKD), Mayo Clinic researchers reported April 3 in JAMA Cardiology.

A new AI software can quickly and accurately determine the manufacturer and model of a cardiac rhythm device from an x-ray, possibly speeding up treatment when the devices fail.

BE'ER SHEVA, Israel — Genoa, Italy — DiA Imaging Analysis, a leading provider of artificial intelligence (AI)-powered ultrasound analysis tools, announced today that it has partnered with the Italian healthcare IT company Ebit (Esaote Group), to offer DiA’s LVivo Cardiac Toolbox as an integrated part of Ebit's SUITESTENSA CVIS (Cardiovascular Information System) PACS.